X
Healthcare Aug 31, 2020 12:45 PM (GMT+8) · EqualOcean
Ezisurg Medical, a Shanghai-based company, announced the close of Series C of multi-hundreds millions of Chinese yuan. Hillhouse Venture Capital led the investment, followed by existing investor China Construction Development Capital. The company focuses on providing integrative solutions for minimally invasive oncology surgeries, including providing precision advanced medical devices and related services. The fierce competition dominated by foreign brands has founded a robust industry position in the market by its core product endoscope.